Skip to main content
Caplight Logo









Oxyco

Oxyco

Private
BarcelonaHealthcare & Life Scienceshttps://oxyco.bio/

Last Round

Accelerator

May 28, 2024

Company Overview

Oxyco operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was an Accelerator round in May 2024.

Oxyco is a biotechnology company that produces sustainable, vegan biomelanin through a proprietary biocatalytic process for applications in food, cosmetics, and nanotechnology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Fashion & Beauty, Clean Manufacturing, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Oxyco Comparables

Compare Oxyco with similar companies based on industry and business-model similarity.

Oxyco comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Melazyme
83%
Crudo Labs
83%
Sparxell
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Oxyco Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 28, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Maria Fátima Lucas

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Oxyco Investors

Notable investors and investment history

Oxyco investors
InvestorRounds
Biotope by VIBAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 28, 2024

    Received funding from Biotope by VIB.

Book a demo to see all signals

For institutional investors. Book with your work email.

Oxyco Filings

Explore SEC and related filing metadata, where available.

Oxyco filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Oxyco's valuation, stock price, and market status.

Is Oxyco a public or private company?

Oxyco is a private company.

What is the current stock price of Oxyco?

Oxyco is a private company, so its shares have no public market price. Caplight tracks Oxyco's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Oxyco worth (valuation)?

Valuation information for Oxyco is not publicly available.

Can I buy Oxyco stock?

Oxyco shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Oxyco's last funding round?

Oxyco's most recent funding round was Accelerator on May 28, 2024.

Who are the main investors in Oxyco?

Key investors in Oxyco include Biotope by VIB.

Will Oxyco IPO soon?

No public IPO plans have been announced for Oxyco.

How can I track Oxyco secondary market activity?

Caplight tracks bids, offers, and trades in Oxyco's shares on secondary markets.

Firmographic Details

HeadquartersBarcelona
Employee Range3
Year Founded2022
Last FundingMay 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?